Acute hepatitis with jaundice F1: Acute or chronic hepatitis with jaundice, liver damages, camp fever or macula typhus, fever, flu or gastritis

1. Acute and chronic hepatitis with jaundice: 61 children in three studies took F1 or its modification for up to three weeks and 58 were cured (95.08 percent), two improved and one did not. 208 adults in two studies took F1 for the same amount of time and 203 were cured (97.59 percent) and five did not improve.

2. Acute liver damage: 63 patients were divided into a treatment group (n=42) using F1 and western medicine together and a comparison group (n=21) using western medicine only. Cured: 41 vs. 15 (97.61 percent vs. 71.42 percent), improved: 1 vs. 5 (2.38 percent vs. 23.80 percent and not improved: 0 vs. 1 (P<0.05). The average treatment time was 25.2 vs. 35.28 days, P<0.01.

3. Typhus: 108 high-fever typhus patients took F1 or its modification from one to seven days and all reported their temperatures returned to normal.

4. Fever: 298 summer flu patients were divided into a treatment group (n=218) who took F1 or its modification and a comparison group took regular medicine for seven days (n=80). Cured: 189 vs. 18 (86.69 percent vs. 22.5 percent), improved: 28 vs. 47 (12.84 percent vs. 58.75 percent) and not improved: 1 vs. 15 (0.45 percent vs. 20 percent). The treatment group was much better than the comparison group, P<0.01.

5. Gastritis: 66 patients took F1 or its modification and 51 were cured (77.27 percent), 5 significantly improved (7.57 percent), 4 improved (6.06 percent) and 6 did not improve. Several other reports also show similar results.